Each year, the Washington University Medical Center Alumni Association has the distinct pleasure of honoring a select group of alumni whose professional achievements, service to the community and dedication to our institution are noteworthy.
The WUMCAA Alumni Awards Subcommittee evaluates nominations each fall as part of the selection process. The Alumni Association Executive Council has the final voting decision.
Eligibility: Washington University School of Medicine alumni members of one of the current year’s MD reunion classes. Nominate alumni who graduated in a class year ending in 0 or 5 for a 2025 award through Nov. 10, 2024. Awardees will be recognized during the 2025 Celebration Weekend.
2024 award recipients
Congratulations to our 2024 Alumni Achievement Award recipients!
David Lubarsky is the CEO of UC Davis Health in Sacramento and Vice Chancellor for Health at UC Davis. He oversees an integrated academic health system, which includes the UC Davis School of Medicine, the Betty Irene Moore School of Nursing, and three hospitals, including the UC Davis Medical Center. The health system has nearly 20,000 employees, 1,000 students, 1,500 faculty members and a large primary care network. UC Davis Health provides care for 50,000 inpatients annually, and has over 2 million outpatient visits each year, and an annual budget of $5 billion.
Since joining UC Davis Health in July 2018, Lubarsky has engineered nation-leading growth, increasing revenues by 70%, and embarking on a historic $7 billion capital campaign, the largest in the nation. In 2023, U.S. News & World Report ranked UC Davis Medical Center ranked as the No. 1 hospital in Sacramento and No. 7 in California. The School of Medicine is ranked in the Top 35 nationally for medical research, and in the Top 10 nationally for primary care and family medicine. The School of Nursing is ranked in the Top 25 nationally for master’s degrees in nursing.
Heralded as a visionary strategist in the business, medical, and civic communities, Lubarsky has personally been recognized as one of the “100 Most Influential People in Health Care” by Modern Healthcare, among “100 Academic Medical Center CEOs to Know” and “60 Health System Influencers” by Becker’s Hospital Review, both in 2023. He was named “CEO of the Year” by Press Ganey in 2022, and a “Most Admired CEO” by the Sacramento Business Journal in 2021.
Under Lubarsky’s guidance, UC Davis Health has expanded patient-centric services lines, developed leading-edge AI and digital capabilities, instituted nationally acclaimed health equity programs, and cultivated regional partnerships. Furthering health equity, he has partnered with Sacramento County to expand care to underserved communities, dramatically increasing the number of Medi-Cal beneficiaries who can access high quality specialty care. Lubarsky has also directed the health system to invest heavily in its surrounding underserved community, and published articles on the impressive impact. These are all part of improving the entire continuum of care for all patients and delivering “tomorrow’s health care today” for all of Northern California.
As a committed academic physician, Lubarsky is a professor of anesthesiology, nursing, and business at UC Davis. Previously he held similar professorial appointments at the University of Miami. During his 16 years in Miami, he served as chief medical officer and systems integration officer where he pioneered greater quality, safety and risk management collaboration among the University, county, and federal entities on that health campus. He was also a long-serving chair of the largest anesthesia training program in the US and founding CEO of the system’s 1,100 physician practice. At Duke University, he served as a professor and vice chair of anesthesiology, and an adjunct professor at Duke’s Fuqua School of Business. He is among the top 100 published anesthesiologists in America.
Lubarsky earned both his undergraduate and medical degree from Washington University in St. Louis. He was the first graduate from their Scholars Program in Medicine (a combined undergraduate/medical degree program). He completed his residency and fellowship at NYU, specializing in cardiovascular anesthesia. He also holds an MBA from the Fuqua School of Business at Duke University where he graduated at the top of the class as a Fuqua Scholar.
Dr. Bruce Molitoris is an Emeritus Distinguished Professor of Medicine at Indiana University. He served as the Director of Nephrology for 18 years, and founded and directed the Indiana Center for Biological Microscopy for 20 years. He has been actively involved in the American Society of Nephrology (ASN) as a member, the ASN Council and served as ASN President in 2012-13.
Throughout his career, Dr. Molitoris has made significant contributions to the field of acute kidney injury research, specifically focusing on proximal tubule cell injury caused by ischemia and nephrotoxins. He has also utilized 2-photon microscopy in live animals to study normal physiology, disease pathophysiology, and therapeutic responses. His research has been supported continuously by grants from the National Institutes of Health (NIH), the Department of Veterans Affairs (VA), and various industry grants. Dr. Molitoris is a founding member of two Biotech LLCs that specialize in 2-Photon and fluorescent technology.
With his expertise, Dr. Molitoris has published over 200 scientific papers in top-tiered scientific journals and has edited or co-edited books, including “Acute Renal Failure,” which complements “The Kidney.” He has been recognized for his teaching contributions and has received both Colorado and Indiana University Trustees teaching awards.
Molitoris earned his undergraduate degree and Master of Science from University of Illinois. He earned his medical degree from Washington University School of Medicine and completed his residency and fellowship training at the University of Colorado School of Medicine. He spent nine years on faculty at the University of Colorado, rising to Professor, and then moved to Indiana University as the Director of Nephrology.
Margaret A. Shipp, MD, is Chief of the Division of Hematologic Neoplasia in the Department of Medical Oncology at Dana-Farber Cancer Institute (DFCI), Director of the Lymphoma Research Center at DFCI and a Professor of Medicine at Harvard Medical School.
Dr. Shipp’s clinical and laboratory research focuses on the clinical and molecular heterogeneity of the large B-cell lymphomas (LBCLs) and Hodgkin lymphomas. Dr. Shipp coordinated the development of the International Prognostic Index which is used worldwide to individualize treatment approaches to LBCLs and many other lymphoid malignancies. More recently, she has led efforts to define molecular signatures of LBCLs and Hodgkin lymphomas, identify biologically distinct subsets of these diseases, and characterize associated rational treatment targets including modulators of the host anti-tumor immune response.
The Shipp group defined recurrent copy gains of chromosome 9p24.1 and associated over-expression of the PD-1 ligands as a targetable genetic basis of immune evasion in classical Hodgkin lymphoma (cHL) and a related lymphoid malignancy. In associated clinical trials, patients with cHL had the highest reported rates of any tumor type to PD-1 blockade, leading to rapid FDA approval of this modality in patients with relapsed cHL and ongoing studies in the frontline setting. The group has also defined mechanisms of response and resistance to PD-1 blockade in this largely MHC class I-negative tumor.
Dr. Shipp is the recipient of numerous awards including an American Cancer Society Junior Faculty Award, a Leukemia Society of America Scholar Award, a Dana-Farber Morse Research Award, designation as a Stohlman Scholar of the Leukemia and Lymphoma Society of America, and a Doris Duke Distinguished Clinical Scientist and membership in the American Society of Clinical Investigation, Association of American Physicians and the Institute of Medicine (National Academy of Medicine), the Gianni Bonadonna Memorial Lecture at the Fourteenth International Conference on Malignant Lymphoma (ICML), the John Ultmann Award for Contributions to Lymphoma Research and Treatment, the DFCI Medical Oncology Discovery Award and the San Salvatore Award at the Seventeenth ICML.
Dr. Shipp received her Doctor of Medicine from Washington University School of Medicine and completed an internal medicine internship and residency at Barnes Hospital/Washington University. Thereafter, she completed a fellowship in Medical Oncology at DFCI and joined the faculty.
Barry A. Siegel, M.D., is currently Professor of Radiology and Medicine at Washington University School of Medicine and a member of the University’s Alvin J. Siteman Cancer Center. Dr. Siegel has been at Washington University since 1962, when he matriculated as an undergraduate. He subsequently attended medical school, followed by medical internship and radiology and nuclear medicine residency at Washington University and served as Director of the Division of Nuclear Medicine of the Mallinckrodt Institute of Radiology from 1973-2017.
Throughout his career, Dr Siegel has been active in nuclear medicine research, and has made contributions related to the diagnosis of pulmonary embolism, the detection of thrombosis, and oncological applications of radionuclide tracers. For the last three decades his research efforts have focused on uses of positron emission tomography for cancer diagnosis and staging, as well as predicting and monitoring tumor response to therapy. He also has been heavily engaged in the development and conduct of multicenter clinical trials in the arena of cancer imaging with PET via leadership roles in both the American College of Surgeons Oncology Group and the American College of Radiology Imaging Network (now the ECOG-ACRIN Cancer Research Group). From 2005-2018 he devoted much of his time to the development and operation of the National Oncologic PET Registry, and those efforts have helped to greatly expand coverage for PET by the Medicare program. More recently, he is also serving as co-chair of the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study, a national study designed to demonstrate the clinical value of brain amyloid PET in patients with mild cognitive impairment or dementia.
Dr. Siegel is a respected clinician at Washington University Medical Center and has been selected by the Mallinckrodt Institute’s radiology residents as an outstanding teacher. The Washington University Medical Center Alumni Association named a Distinguished Alumni Scholarship in his honor in 1997 and gave him an Alumni Faculty Award in 2004. Most recently, the medical school honored him with its Distinguished Clinician Award in 2013 and Barnes-Jewish Hospital gave him its Lifetime Achievement Award in 2015.
Bruce Wintroub served as the Chair of the Department of Dermatology at UCSF from 1985 to 2022, making him the longest-serving department chair in UCSF history. From its humble beginnings with eight members, it has transformed into one of the world’s largest dermatology programs. Today, it boasts 43 full-time faculty, 21 residents, 10 fellows, and 150 staff members. It is widely regarded as one of the top dermatology departments in the United States, excelling in science, education, and clinical programs.
Wintroub’s leadership and vision have been pivotal in shaping the department’s success. He has personally trained or recruited the entire current faculty, drawing upon resources acquired through a thriving clinical practice and philanthropy. The department’s scientific programs, such as cutaneous oncology, immunology and inflammation, biology of the skin barrier, health services research, and epidemiology, receive substantial funding and have achieved significant accomplishments. The department has also established various clinical research programs.
Wintroub has held multiple roles within the Dermatology Foundation including president or chairman for over sixteen years. Through his leadership, the foundation has invested more than $60 million to support young dermatology investigators, teachers, and clinical scholars, ensuring a sustainable influx of talent into the field.
Bruce’s impact extends beyond the Department of Dermatology. He has held various positions within the UCSF School of Medicine, including Associate, Vice Dean, Executive Vice Dean, and Interim Dean. He played a crucial role in the acquisition and merger of Mt Zion Hospital into the UCSF system, which led to the development of the UCSF Hellen Diller Comprehensive Cancer Center. Bruce has been involved in strategic planning, clinical mergers, and space management for the entire UCSF campus, including key construction projects.
During his tenure as Interim Dean, Bruce addressed important issues within UCSF. In response to the White Coat for Black Lives movement, he organized a retreat involving the entire UCSF leadership to emphasize the institution’s commitment to diversity and inclusion. He also focused on promoting diversity within dermatology, challenging the field to develop solutions and actively recruit underrepresented in medicine (UIM) physicians.
Past award recipients
2023
Vineet Arora, MD ’98
Carol North, MD ’83, HS ’87, ’90; GME ’93
Audrey Rostov, MD ’88, HS ’92
Richard Wahl, MD ’78, HS ’82, ’83
2022
Pamela G. Freeman, MD ’77
Jondavid Menteer, MD ’97
Leana S. Wen, MD ’07
2021
Sam B. Bhayani, MD ’96, HS ’98, HS ’02
Ellen F. Binder, MD ’81
Gary D. Luker, MD ’91
Mark A. Mintun, MD ’81, HS ’85
Jeffrey G. Ojemann, MD ’92, HS ’99 (reunion year ’91)
Janice Wann Semenkovich, MD ’81
2020
George A. Mensah, MD ’85
Scott A. Mirowitz, MD ’85, HS ’89
Bradley L. Schlaggar, MD/PhD ’94, HS ’99 (reunion year ’90)
James L. Sweatt III, MD ’62
Peter Westervelt, MD/PhD ’92; HS ’94, HS ’99 (reunion year ’90)
2019
Andrew C. Chan, MD/PhD ’86, HS ’89 (reunion year ’84)
Ann Randolph Flipse, MD ’59, HS ’61
Gurjit K. Khurana Hershey, MD/PhD ’92, HS ’97 (reunion year ’89)
William E. Klunk, MD/PhD ’84
Mary V. Mason, MD ’94, HS ’98, MBA ’99
2018
Richard J. Auchus, MD/PhD ’88
Brad T. Cookson, MD/PhD ’91
Mark E. Frisse, MD ’78, HS ’82, MBA ’97
V. Michael Holers, MD ’78, HS ’85
Lisa M. Moscoso, MD/PhD ’98, HS ’02
2017
Thomas R. Burklow, MD ’87
J. William Campbell, MD ’77, HS ’80
Gary A. Ratkin, MD ’67, HS ’72
Charles W.M. Roberts, MD/PhD ’95
2016
Robert H. Allen, MD ’66, HS ’76
Nancy L. Bartlett, MD ’86
Deborah Veis Novack, PhD/MD ’95, HS ’00
C. Leon Partain, PhD, MD ’75
Eric T. Vaughn, MD ’91
2015
William A. Blattner, MD ’70
C. Robert Cloninger, MD’70, HS
Ellen Li, MD/PhD ’80
Joseph R. Williamson, MD ’58
2014
Jerry Cohen, MD ’64, HS ’71
C. James Holliman, MD ’79
Charles C. Norland, MD ’59
J. Andy Sullivan, MD ’69, HS ’74
2013
John Constantino, MD ’88
Sandeep Jauhar, MD ’98, PhD
Joseph K.T. Lee, MD ’73
Stephen Young, MD ’78
2012
Keith Bridwell, MD ‘77
Warner C. Greene, MD, PhD ’77
Gary S. Rachelefsky, MD ‘67
Pejman Salimpour, MD ‘87
2011
Richard L. Baron, MD ’76
Michael J. Lenardo, MD ’81
Kathleen Brogan Schwarz, MD ’72
Ira A. Tabas, MD ’81
2010
Floyd E. Bloom, MD ’60
Dan R. Littman, MD ’80
2009
Michael Georgieff, MD ’79
David Hussey, MD ’64
2008
R. Edward Coleman, MD ’68
Charles O. Elson, III, MD ’68
Alexander Gottschalk, MD ’58
James P. McCulley, MD ’68
2007
Michael Adams, MD ’67
David D. Chaplin, MD ’80, PhD ’80
Guido Guidotti, MD, PhD ’57
John H. Stone III, MD ’62
2006
Marshall E. Bloom, MD ’71
Willard B. Walker, MD ’46
2005
James E. Darnell Jr., MD ’55
Eric D. Green, MD, PhD ’87, HS ’91
2004
Danny O. Jacobs, MD ’79
David E. Smith Jr., MD ’44
2003
Barry M. Farr, MD ’78
W. Allan Walker, MD ’63
2002
Ewald W. Busse, MD ’42
Robert D. Fry, MD ’72
Charlotte D. Jacobs, MD ’72
Clifford B. Saper, MD, PhD ’77
2001
Herbert T. Abelson, MD ’66
Theodore C. Feierabend, MD ’51
Frank Vellios, MD ’46
2000
Clay M. Armstrong, MD ’60
Richard L. Landau, MD ’40
William T. Shearer, MD, PhD ’70
1999
C. Garrison Fathman, MD ’69
Robert E. Hermann, MD ’54
Carolyn Robinowitz, MD ’64
1998
William B. Blythe, MD ’53
John I. Sandson, MD ’53
Lynn M. Taussig, MD ’68
1997
John M. Eisenberg, MD ’72
Helen Hofsommer Glaser, MD ’47
Kenneth R. Smith Jr., MD ’57
1996
Gladden V. Elliott, MD ’46
Lowell A. Gess, MD ’51
Larry J. Shapiro, MD ’71
1995
Philip O. Alderson, MD ’70
Dennis P. Cantwell, MD ’65
Margaret C. Telfer, MD ’65
1994
Samuel P. Bessman, MD ’44
A. Martin Lerner, MD ’54
Raymond G. Schultze, MD ’59
1993
Joseph M. Davie, MD, PhD ’68
Gerald T. Perkoff, MD ’48
Edwin W. Salzman, MD ’53
1992
Harry S. Jonas, MD ’52
Brent M. Parker, MD ’52
Robert D. Utiger, MD ’57
1991
Ronald G. Evens, MD ’64
Lawrence W. O’Neal, MD ’46
Meredith J. Payne, MD ’50
1990
Purnell W. Choppin, MD, HS
Leonard Jarett, MD ’62
Dorothy D. Reister, MD ’50
1989
Richard ‘David’ Aach, MD ’59
Charles L. Eckert, MD ’39
Jonathan Mann, MD ’74
1988
Henry L. Barnett, MD ’38
Edwin G. Krebs, MD ’43
Seymour Reichlin, MD ’48
1987
Pedro Cuatrecasas, MD ’62
Alfred Gellhorn, MD ’37
C. Barber Mueller, MD ’42
1986
Robert M. Filler, MD ’56
Thomas F. Hornbein, MD ’56
Kenneth E. Pletcher, MD ’36
1985
Ralph Berg Jr., MD ’45
John P. Roberts, MD ’45
Richard A. Sutter, MD ’35
1984
Daniel Nathans, MD ’54
Albert L. Rhoton Jr., MD ’59
David W. Talmage, MD ’44
1983
Jack Barrow, MD ’46
Russell J. Blattner, MD ’33
C. Read Boles, MD ’43
Samuel D. Soule, MD ’28
1982
Carroll Behrhorst, MD ’47
George Sato, MD ’47
Hugh E. Stephenson Jr., MD ’45